Core Viewpoint - Sino Medical (688108) experienced a decline in stock price, closing at 22.32 yuan on February 27, 2026, with a trading volume of 119,900 shares and a turnover of 268 million yuan [1]. Group 1: Financial Performance - For the first three quarters of 2025, Sino Medical reported a main revenue of 364 million yuan, an increase of 14.24% year-on-year [3]. - The net profit attributable to shareholders reached 21.12 million yuan, showing a significant increase of 293.46% year-on-year [3]. - The company's third-quarter revenue was 123 million yuan, up 17.73% year-on-year, with a net profit of 7.28 million yuan, reflecting a 150.51% increase year-on-year [3]. - The gross profit margin stood at 65.7%, with a debt ratio of 30.4% and financial expenses amounting to 3.22 million yuan [3]. Group 2: Capital Flow - On February 27, 2026, the net outflow of main funds was 76.82 million yuan, accounting for 28.62% of the total turnover, while retail investors saw a net inflow of 43.03 million yuan, representing 16.03% of the total turnover [1]. - The financing data indicated a financing buy of 19.97 million yuan and a financing repayment of 22.92 million yuan, resulting in a net repayment of 2.95 million yuan [2]. - The margin trading balance stood at 820 million yuan, with a short selling balance of 239,600 yuan [2].
赛诺医疗(688108)2月27日主力资金净卖出7682.42万元